Article
Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency
13 Nov 2017
Abstract excerpt
BACKGROUND: Epstein-Barr virus (EBV) exhibits both lytic and latent (Lat. I, II, and III) phases in an infected individual. It's during the latent phase of EBV that all EBV-associated cancers, including Burkitt's lymphoma, nasopharyngeal carcinoma and lymphoproliferative disease arise. Interferon-γ-inducible protein 16 (IFI16) is a well-established innate immune sensor and viral transcriptional regulator involved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
